Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9XS59

Entry ID Method Resolution Chain Position Source
AF-Q9XS59-F1 Predicted AlphaFoldDB

107 variants for Q9XS59

Variant ID(s) Position Change Description Diseaes Association Provenance
rs444270209 7 V>G No EVA
rs482203481 32 D>A No EVA
rs474589420 61 R>I No EVA
rs462034382 86 R>G No EVA
rs441811360 89 Y>F No EVA
rs441811360 89 Y>S No EVA
rs439780196 94 N>K No EVA
rs520934212 95 G>R No EVA
rs470013301 98 A>G No EVA
rs450142341 99 Y>S No EVA
rs461295605 100 L>H No EVA
rs481607177 100 L>I No EVA
rs441139686 104 L>V No EVA
rs459041192 108 L>P No EVA
rs459041192 108 L>R No EVA
rs439132210 110 I>V No EVA
rs456712554 115 F>V No EVA
rs443027677 121 V>A No EVA
rs438302073 134 N>S No EVA
rs476257164 151 C>* No EVA
rs436298309 154 V>A No EVA
rs473788895 157 Y>H No EVA
rs453746889 158 Y>F No EVA
rs453746889 158 Y>S No EVA
rs433775467 159 N>H No EVA
rs445338137 160 V>A No EVA
rs465376530 160 V>L No EVA
rs469452542 161 I>N No EVA
rs448264817 165 S>G No EVA
rs480946557 165 S>R No EVA
rs436214424 168 Y>F No EVA
rs447034952 169 F>C No EVA
rs478454730 174 Q>L No EVA
rs458535539 178 P>A No EVA
rs458535539 178 P>T No EVA
rs438524987 179 W>L No EVA
rs482682746 181 Q>H No EVA
rs442393553 184 L>* No EVA
rs473876994 185 V>M No EVA
rs453885681 186 K>E No EVA
rs798738382 190 H>D No EVA
rs134826380 235 A>S No EVA
rs452314413 296 P>Q No EVA
rs472264395 302 A>D No EVA
rs438710114 322 S>I No EVA
rs135798331 329 N>H No EVA
rs137170155 329 N>T No EVA
rs381244523 354 A>V No EVA
rs476198108 368 I>V No EVA
rs714581494 372 S>L No EVA
rs433971146 397 A>G No EVA
rs454247916 397 A>S No EVA
rs465402092 399 T>P No EVA
rs1114910970 428 I>V No EVA
rs469699602 429 E>D No EVA
rs449456073 430 D>E No EVA
rs480827812 433 N>H No EVA
rs458601651 435 A>S No EVA
rs478043200 439 T>A No EVA
rs482434947 442 A>D No EVA
rs797139263 478 T>I No EVA
rs460317057 498 T>P No EVA
rs446750306 521 V>G No EVA
rs461476685 553 F>L No EVA
rs473031057 559 D>A No EVA
rs432735760 560 M>R No EVA
rs452995437 560 M>V No EVA
rs457206774 570 Y>* No EVA
rs437059415 571 Y>* No EVA
rs468519560 572 M>L No EVA
rs448138205 575 Y>N No EVA
rs434588655 580 M>R No EVA
rs721710241 586 I>V No EVA
rs446172240 588 S>T No EVA
rs477184408 590 V>A No EVA
rs463618044 591 N>D No EVA
rs450012950 606 K>Q No EVA
rs440434742 611 F>L No EVA
rs445418075 612 L>V No EVA
rs483239589 613 S>R No EVA
rs443371470 614 Y>* No EVA
rs463445624 614 Y>F No EVA
rs463445624 614 Y>S No EVA
rs378221265 616 T>M No EVA
rs722716917 616 T>P No EVA
rs461485885 620 V>A No EVA
rs472486641 624 S>Y No EVA
rs452301924 625 L>V No EVA
rs438554261 629 A>V No EVA
rs476263812 631 L>M No EVA
rs456453762 631 L>W No EVA
rs467859624 634 P>T No EVA
rs454053222 638 I>L No EVA
rs465653374 641 R>L No EVA
rs438183396 647 D>V No EVA
rs469610173 652 L>S No EVA
rs449408756 653 A>V No EVA
rs481128040 674 A>E No EVA
rs478689535 675 S>I No EVA
rs447198105 675 S>R No EVA
rs458675452 680 K>* No EVA
rs442893020 691 G>C No EVA
rs442615709 706 T>P No EVA
rs474284347 707 A>D No EVA
rs471819605 708 P>L No EVA
rs433967952 708 P>T No EVA
rs475378288 716 Y>D No EVA

No associated diseases with Q9XS59

1 regional properties for Q9XS59

Type Name Position InterPro Accession
domain B(0)AT2, solute-binding domain 61 - 640 IPR042934

Functions

Description
EC Number
Subcellular Localization
  • Membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

3 GO annotations of molecular function

Name Definition
branched-chain amino acid:sodium symporter activity Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: branched-chain amino acid(out) + cation(out) = branched-chain amino acid(in) + cation(in).
neutral amino acid:sodium symporter activity Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: neutral amino acid(out) + Na+(out) = neutral amino acid(in) + Na+(in).
proline:sodium symporter activity Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: proline(out) + Na+(out) = proline(in) + Na+(in).

5 GO annotations of biological process

Name Definition
leucine transport The directed movement of leucine, 2-amino-4-methylpentanoic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
neurotransmitter transport The directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Neurotransmitters are any chemical substance that is capable of transmitting (or inhibiting the transmission of) a nerve impulse from a neuron to another cell.
neutral amino acid transport The directed movement of neutral amino acids, amino acids with no net charge, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
proline transport The directed movement of proline, pyrrolidine-2-carboxylic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
sodium ion transmembrane transport A process in which a sodium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.

15 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O18875 SLC6A8 Sodium- and chloride-dependent creatine transporter 1 Bos taurus (Bovine) PR
Q9MZ34 SLC6A6 Sodium- and chloride-dependent taurine transporter Bos taurus (Bovine) PR
P51143 SLC6A2 Sodium-dependent noradrenaline transporter Bos taurus (Bovine) PR
P23975 SLC6A2 Sodium-dependent noradrenaline transporter Homo sapiens (Human) PR
Q9GZN6 SLC6A16 Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 Homo sapiens (Human) PR
Q9H1V8 SLC6A17 Sodium-dependent neutral amino acid transporter SLC6A17 Homo sapiens (Human) PR
Q9H2J7 SLC6A15 Sodium-dependent neutral amino acid transporter B(0)AT2 Homo sapiens (Human) PR
Q9D687 Slc6a19 Sodium-dependent neutral amino acid transporter B(0)AT1 Mus musculus (Mouse) PR
O88576 Slc6a18 Sodium-dependent neutral amino acid transporter B(0)AT3 Mus musculus (Mouse) PR
O88575 Slc6a20b Sodium- and chloride-dependent transporter XTRP3B Mus musculus (Mouse) PR
Q8BJI1 Slc6a17 Sodium-dependent neutral amino acid transporter SLC6A17 Mus musculus (Mouse) PR
O55192 Slc6a2 Sodium-dependent noradrenaline transporter Mus musculus (Mouse) PR
Q64093 Slc6a20 Sodium- and chloride-dependent transporter XTRP3 Rattus norvegicus (Rat) PR
Q62687 Slc6a18 Sodium-dependent neutral amino acid transporter B(0)AT3 Rattus norvegicus (Rat) PR
P31662 Slc6a17 Sodium-dependent neutral amino acid transporter SLC6A17 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MPKNSKVVKR ELDDEVIESV KDLLSNEDSA DDAFKKSELI VDVPEEKDTD VVERSEVKDA
70 80 90 100 110 120
RPAWNSKLQY ILAQVGFSVG LGNVWRFPYL CQKNGGGAYL LPYLILLLVI GIPLFFLELS
130 140 150 160 170 180
VGQRIRRGSI GVWNYISPQL GGIGFASCVV CFFVALYYNV IIGWSLFYFS QSFQQPLPWD
190 200 210 220 230 240
QCPLVKNASH TFVEPECEKS SATTYYWYRE ALNISTSISE SGGLNWKMTI CLLAAWVVVC
250 260 270 280 290 300
LAMIKGIQSS GKIMYFSSLF PYVVLICFLI RALLLNGSVD GIRHMFTPEL EIMLEPKVWR
310 320 330 340 350 360
EAAAQVFFAL GLGFGGVIAF SSYNKRDNNC HFDAVLVSFI NFFTSILATL VVFAVLGFKA
370 380 390 400 410 420
NVINEKCIAE NSEMIIKLVK MGNISQDIIP HHINFSAITA EDYDLIYDII QKVKEEEFPA
430 440 450 460 470 480
LHLNACQIED ELNKAVQGTG LAFIAFTEAM THFPASPFWS VMFFLMLVNL GLGSMFGTIE
490 500 510 520 530 540
GIITPVVDTF KVRKEILTVI CCLLAFCIGL IFVQRSGNYF VTMFDDYSAT LPLLIVVILE
550 560 570 580 590 600
NIAVSFVYGI DKFMEDLKDM LGFTPNRYYY YMWKYISPLM LLSLLIASIV NMGLSPPGYN
610 620 630 640 650 660
AWMEDKASEK FLSYPTWGMV ICISLMVLAI LPIPVVFIIR RCNLIDDSSG NLASVTYKRG
670 680 690 700 710 720
RVLKEPVNLE GDDASLIHGK ISSEMSSPNF GKNIYRKQSG SPTLDTAPNG RYGIGYLMAD
MPDMPESDL